Jolanta Grydehøj

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft et al. · Annals of the Rheumatic Diseases · 2017 · 245 citations

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Bente Glintborg, Anne Gitte Loft, Emina Omerovic et al. · Annals of the Rheumatic Diseases · 2018 · 153 citations · Full text

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

Else Helene Ibfelt, Jan Sørensen, Dorte Vendelbo Jensen et al. · Clinical Epidemiology · 2017 · 92 citations · Full text

Levetiracetam in spinal cord injury pain: a randomized controlled trial

Nanna Brix Finnerup, Jolanta Grydehøj, J. Bing et al. · Spinal Cord · 2009 · 79 citations · Full text

Pain Therapy, Spinal Cord Injury, Health Sciences +10

Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry

Tanja Schjødt Jørgensen, Lars Erik Kristensen, Robin Christensen et al. · Lara D. Veeken · 2015 · 56 citations